Barry Fishman

Part of Deloitte LLP (New York), Deloitte Development LLC provides legal and auditing services. The company is based in New York, NY.

Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada.

Norgine BV engages in development and manufacture of pharmaceutical products. It is specialized in gastroenterology, hepatology, cancer, and supportive care. The firms brands include Depoint, Elantan, Emselex, Estraderm, Givalex, Isoket, Nortussine, Provames, Sintrom, Speciafoldine, Surgestone, and Tredemine. The company was founded by Victor Stein in 1906 and is headquartered in Amsterdam, the Netherlands.

ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom.

Akerna Corp. engages in the provision of software as a service solutions within the cannabis industry that enable regulatory compliance and inventory management. The firm also provides project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements. The company was founded on June 17, 2019 and is headquartered in Denver, CO.

Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. It offers psychedelic-enhanced and psychedelic-integration psychotherapy. The firm is developing patient-centric and evidence-based psychedelic approaches to behavioral and mental health. The company was founded by Joseph del Moral, Ronan Levy, Hannan Fleiman, Syed Mujeeb Jafferi, and Ryan Yermus on September 30, 2008 and is headquartered in Toronto, Canada.

Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism.

Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada.